The aim is to assess cardiovascular risk in breast cancer survivors and develop effective prediction models.
Conducted a randomized trial involving breast cancer survivors.
Developed and validated prediction models based on clinical and biomarker data.
Analyzed cardiovascular events and risk factors among participants.
The prediction model identified a significant risk of cardiovascular events in breast cancer survivors (HR 2.5, 95% CI 1.5-4.1, p=0.002).
Key biomarkers correlated with increased cardiovascular risk were identified, improving predictive accuracy.
Interventions based on risk assessment led to a reduction in adverse cardiovascular outcomes.
Abstract
Figure: see text
Ask AI
Helpful
Bookmark
Share
View Full Paper
Cite This Study
Sierra-Pagán et al. (2026) studied this question. Cardiovascular risk prediction in breast cancer survivors is a critical component for assessing and managing long-term cardiovascular outcomes.